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Abstract
Background: Disease management programmes are increasingly used to improve the efficacy and effectiveness of chronic care delivery.
But, disease management programme development and implementation is a complex undertaking that requires effective decision-making.
Choices made in the earliest phases of programme development are crucial, as they ultimately impact costs, outcomes and sustainability.
Methods: To increase our understanding of the choices that primary healthcare practices face when implementing such programmes and
to stimulate successful implementation and sustainability, we compared the early implementation of eight cardiovascular disease manage-
ment programmes initiated and managed by healthcare practices in various regions of the Netherlands. Using a mixed-methods design, we
identified differences in and challenges to programme implementation in terms of context, patient characteristics, disease management
level, healthcare utilisation costs, development costs and health-related quality of life.
Results: Shifting to a multidisciplinary, patient-centred care pathway approach to disease management is demanding for organisations,
professionals and patients, and is especially vulnerable when sustainable change is the goal. Funding is an important barrier to sustainable
implementation of cardiovascular disease management programmes, although development costs of the individual programmes varied
considerably in relation to the length of the development period. The large number of professionals involved in combination with duration
of programme development was the largest cost drivers. While Information and Communication Technology systems to support the new
care pathways did not directly contribute to higher costs, delays in implementation indirectly did.
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Conclusions: Developing and implementing cardiovascular disease management programmes is time-consuming and challenging. Mul-
tidisciplinary, patient-centred care demands multifaceted changes in routine care. As care pathways become more complex, they also
become more expensive. Better preparedness and training can prevent unnecessary delays during the implementation period and are cru-
cial to reducing costs.
Keywords
cardiovascular disease management, integrated care pathways, chronic care delivery, programme implementation,
the Netherlands
Introduction
Chronic diseases are major causes of death and dis-
ability worldwide, and the prevalence of such diseases
is increasing [1]. They pose a significant health threat
and an increasing challenge to healthcare systems.
Despite advances in treatment, patients with chronic
diseases often do not receive optimal care [2]. Because
the causes of chronic diseases are complex, treatment
should be multifaceted, integrated, and tailored to
patient needs [3].
To improve the efficiency and effectiveness of chronic
care delivery, health systems increasingly develop
and implement structured disease management pro-
grammes as an integrated part of primary care [4–6].
We argue that these programmes can be considered
as specific forms of integrated care pathways, focused
on providing multi-disciplinary, patient-centred care.
Two types of disease management models have been
presented in the literature: (1) commercial disease
management programmes and (2) primary care dis-
ease management programmes based on the chronic
care model introduced by Edward Wagner [6]. The
chronic care model was developed as a foundation for
redesigning primary care practices and improving the
quality of chronic care. Whereas commercialised dis-
ease management programmes target only patients,
those based on the chronic care model are aimed at
both patients and professionals, providing an orga-
nised multidisciplinary approach to the delivery of
care and stimulating communication between profes-
sionals and well-informed patients [7]. In the Nether-
lands, disease management programmes are based
on the chronic care model [7–11], albeit adjusted to fit
with Dutch healthcare practices [12]. The chronic care
model forms the basis for effective chronic care man-
agement and addresses shortcomings in acute care
models by identifying essential elements that encou-
rage high-quality chronic care delivery [13–15] through
the combination of patient-related, professional-direc-
ted, and organisational interventions [16,17]. It includes
six interrelated components of quality of chronic
care delivery: ‘self-management support’, ‘delivery
system design’, ‘decision support’, ‘clinical information
systems’, ‘healthcare organisation’, and ‘community
linkages’ [13–15]. Primary care practices that employ
the chronic care model support self-
management abilities of chronically ill patients through
education, lifestyle programs, and skills building
(self-management support), redesign the way care is
delivered to chronically ill patients (delivery system
design), use evidence (e.g. care standards and clinical
guidelines) to provide quality of care (decision support),
and implement information systems to improve com-
munication and coordination among professionals,
provide timely reminders, feedback, and other methods
that increased their visibility at the time of clinical
decision-making, monitor effectiveness of care for indi-
vidual patients (clinical information systems) [7,18].
These four dimensions of chronic care delivery in
primary care practices are situated in the larger context
of health systems that value and provide incentives for
improved quality of chronic care delivery (healthcare
organisation) and a community that supports chronic
care delivery (community linkages) [18].
Effective disease management is best accomplished
by a combination of multiple interventions and
collaborations among various professionals, with the
support of a variety of health care resources; however,
many organisational options are available and
programme designers face numerous choices and
challenges. Moreover, programmes based on the
chronic care model are complex, time-consuming, and
costly to implement. Disease management programme
implementation therefore requires effective decision
making by primary care practices– a process that is
increasingly difficult in a time of simultaneous reduced
health care budgets and pressure to increase effective-
ness and efficiency.
In absence of a ‘one size fits all’ model, practices
intending to develop and implement a disease man-
agement programme struggle with the multitude of
available choices. Even for a single chronic disease,
approaches chosen in practice may vary widely, espe-
cially in different contexts or settings. This diversity
may lead to varying programme costs, health out-
comes and improvements in care delivery, depending
upon the health care setting, disease, and/or target
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group [19,20]. Evidence of the effects of disease
management programmes on quality of care delivery,
quality of life outcomes and efficiency is largely incon-
clusive [21–23]. Earlier studies, for example, showed
that some of the elements of the chronic care model
are implemented by care practices with more ease
and in greater depth compared to others [24]. Their
study revealed that information and communication
systems received the most attention, while community
linkages received the least attention. Furthermore, in
a meta-analysis on cost-effectiveness of the chronic
care model in the new millennium Coleman and collea-
gues [25] concluded that results vary widely and the
cost-effectiveness of the chronic care model is just
beginning to emerge. In addition, Tsai and colleagues
[23] found in their meta-analysis that results on effec-
tiveness of implementing interventions that incorporate
one or more elements of the chronic care model
for quality of life of patients were mixed. These varia-
tions may be explained, in part, by the choices made
in the early stages of programme design and
implementation.
In this paper, we describe the varieties in patient charac-
teristics, quality of chronic care delivery, health care
utilisation costs, development costs, and patient out-
comes among newly developed cardiovascular disease
management programmes in the Netherlands. We
followed eight cardiovascular disease management
programmes during the early stages of implementation
in various Dutch regions. Given the challenging task of
implementing complex, multi-component interventions
and of transitioning from acute to (multidisciplinary,
patient-centred) chronic care pathways, we examined
the processes and challenges of developing and imple-
menting cardiovascular disease management pro-
grammes in the Netherlands. We investigated
differences among these programmes in terms of con-
text, patient characteristics, disease management level,
health care utilisation costs, programme development
costs, and patients’ health-related quality of life.
Methods
Setting
Our study was performed in the context of a national
programme on ‘disease management of chronic dis-
eases’. Requirements of the national programme
were that the practices had to have some experience
with the delivery of integrated chronic care and were
equipped to implement multiple systems needed for
the delivery of sufficient chronic care, which resulted
in the inclusion of 22 disease management pro-
grammes (out of 38 applications to participate in the
national programme). These disease management
programmes targeted several patient populations: car-
diovascular diseases, chronic obstructive pulmonary
disease, diabetes, heart failure, stroke, patients with
multiple of these morbidities, depression, psychotic dis-
eases, and eating disorders. For this study we selected
the eight cardiovascular disease management pro-
grammes known as the ‘Vitale Vaten’ project. These
eight projects implemented disease management inter-
ventions in 39 healthcare practices in eight regions in
the Netherlands (see Appendix for an overview of
regions and implemented interventions).
To describe these eight cardiovascular disease man-
agement programmes, we used a concurrent nested
mixed-methods approach [26]. We collected baseline
quantitative data on the patient and organisational
levels during the early implementation stage of the
eight programmes. We also conducted baseline inter-
views with project leaders from all cardiovascular dis-
ease management programmes (n=8) and additional
in-depth interviews with managers and caregivers of
one programme (n=3) to identify barriers and chal-
lenges during early programme implementation. We
further describe the research setting, methods and
analysis. A detailed description of the methods we
employed in our research can also be found in our
study protocol [27].
Although the care provision structure varies among the
eight programmes, they share target patient groups
and most include collaboration between general practi-
tioners, physiotherapists, and dieticians, as well as
related practice redesign aimed at improving effective
chronic-care management. The disease management
programmes aim to overcome shortcomings in acute
care models by implementing elements that encourage
high-quality chronic disease care.
Each cardiovascular disease management programme
consists of a combination of patient-related, profession-
ally directed, and organisational interventions (see
Appendix for detailed programme information).
Patient-related interventions
All eight cardiovascular disease management pro-
grammes included self-management interventions,
e.g. patient education on lifestyle, regulatory skills,
and/or proactive coping.
Professionally directed interventions
Implementation of the disease management pro-
grammes was based on a set of carestandards, guide-
lines, and protocols and supported by information and
communications technology tools such as integrated
information systems. All programmes provided training
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for care providers. There was some variance in profes-
sion-specific items in the implementation strategies for
professional interventions.
Organisational interventions
These interventions varied among cardiovascular dis-
ease management programmes. Examples include
new care provider collaborations, reallocation of tasks,
more effective information transfer and appointment
scheduling, and case management. Some organisa-
tional interventions were related to professional
interventions: employing new types of health profes-
sionals, redefining professionals’ roles and/or redistri-
buting their tasks, re-structuring interaction between
professionals, and planning regular follow-up meetings
by the care team.
Patients
Although all eight disease management programmes
focus on patients at risk of (repeated) cardiovascular
incident, they targeted different patient populations
(Table 1). Two programmes focus exclusively on
patients with a history of cardiovascular incidents, three
focus exclusively on high-risk patients, one focuses on
a combination of patients with previous incidents and
high risk patients and the remaining two focus on
patients with either high or low risk for cardiovascular
disease. No additional inclusion criteria were applied
in the programmes. A questionnaire was sent to the
2760 enrolees of the eight cardiovascular disease
management programmes to acquire baseline mea-
surements. The response rate was 54% (n=1484).
The study was approved by the ethics committee of
the Erasmus University Medical Centre of Rotterdam
in September 2009. Data were collected anonymously
and treated confidentially to protect sensitive patient
information.
Quantitative study - measurements
The quantitative study used the following outcome
measurements: differences in perceived disease man-
agement level, patient characteristics, costs of both
programme development and healthcare utilisation,
and health-related quality of life. Diseasemanagement
level from the patient's perspective was ascertained
by administering the 20-item Patient Assessment of
Chronic Illness Care (PACIC) questionnaire [28–30].
The Patient Assessment of Chronic Illness Care mea-
sures, from the patient's perspective, the extent to
which the last 6 months of delivered care aligns with
the chronic care model. Its subscales address (1)
patient activation, (2) delivery system design, (3) goal
setting, (4) problem solving, and (5) follow-up/coordina-
tion. Example of items are: when I received care for my
chronic illness I was given choices on treatment to think
about; satisfied that my care was well organised; asked
how my chronic illness affects my life; told how my vis-
its with other types of doctors, like the cardiac surgeon,
helped my treatment. The Patient Assessment of
Chronic Illness Care was scored by summing each par-
ticipant's responses to all 20 items, then dividing by 20,
the number of items in the scale. Missing values were
replaced by mean scale scores if respondents filled in
at least 2/3 of the items of a scale. Scores thus ranged
from 1 to 5, with higher scores indicating higher quality
of chronic care delivery as perceived by patients.
The EuroQol-5 Dimensions questionnaire was used to
estimate the utility that patients attached to their health
status [31]. The questionnaire consists of five dimen-
sions (mobility, self-care, usual activities, pain/discom-
fort, anxiety/depression) each of which can take one
of three answering categories. Utilities were calculated
using the Dutch EuroQol-5 Dimension values set [32].
Basic demographic data on age, gender, marital status,
and educational level were gathered. Educational level
Table 1. Overview of the cardiovascular disease management programmes
Cardiovascular disease management programmes Patient population
Onze Lieve Vrouwe Gasthuis (OLVG) Diagnosed with a cardiovascular disease
Stichting Eerstelijns Samenwerking Achterveld (SESA) Diagnosed with a cardiovascular disease and high-risk patients
Regionale Organisatie Huisartsen Amsterdam (ROHA) Diagnosed with a cardiovascular disease
Stichting Gezondheidscentra Eindhoven (SGE) High-risk patients
Gezondheidscentrum Maarssenbroek (Maarssenbroek) Low and high-risk patients
Ziekenhuis Rijnstate (Rijnstate) High-risk patients
Universitair Medisch Centrum St Radboud (Radboud) Low and high-risk patients
Wijkgezondheidscentra Huizen (Huizen) High-risk patients
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was dichotomised into ‘low’ and ‘high’, with low repre-
senting no or only some primary/secondary education.
We estimated the development costs for each disease
management programme by including costs such as
labour costs for brainstorming sessions, professional
training costs, material costs, capital costs for Informa-
tion and Communication Technology that occurred in
the preparation phase of a programme. The implemen-
tation costs that occurred after the start of providing dis-
ease management interventions to the patients (e.g.
costs of managing a programme, the costs of multidis-
ciplinary team meetings, the costs of materials used for
patient education, the costs of keeping the Information
and Communication Technology operating etc.) are
not included in this analysis. The development costs
were collected and estimated using a cost-price analy-
tic tool based on the ‘CostIt’ tool developed by the
World Health Organisation [33]. This tool was adjusted
to allow cost-price calculation in the context of a dis-
ease management programme, which facilitated uni-
form data collection across the eight programmes.
The cost-price calculation requires detailed data on
capital costs, labour costs, training costs, material
costs, maintenance costs of equipment and technol-
ogy, etc. This information was collected in face-to-face
and telephone interviews with programme managers
and financial administrators.
The costs of health care utilisation were also esti-
mated. For this measurement, patients were asked to
complete a questionnaire about their health care utili-
sation in the previous 3 months. The questionnaire
included detailed questions about visits to general
practitioners, visits to medical specialists, paramedical
professionals, nurses, emergency departments, medi-
cation use, hospitalisation and ambulance use. Self-
reported health care utilisation was multiplied with
2010 unit costs that were mainly obtained from the
Dutch manual of guideline prices for use in economic
evaluation studies [34].
Quantitative study - analysis
Descriptive analyses were performed to compare
patient characteristics, experiences with chronic care,
health-related quality of life, development costs and
healthcare utilisation costs across disease manage-
ment programmes. Differences among programmes
were established with chi-squared tests and analysis
of variance. Multiple regression analysis was per-
formed to investigate relationships among pro-
grammes, patient characteristics, and health-related
quality of life.
Qualitative study - interviews
Baseline interviews were conducted in all of the cardio-
vascular disease management programmes (n=8)
within three months of selection for funding through
the national programme. The baseline interviews
served multiple purposes: to understand the organisa-
tion, roles, and responsibilities of the project team; to
learn about the goals of the project from the project lea-
der's point of view and to gain an overview of all pro-
jects so that one programme could be selected
as a case study site for further in-depth qualitative
research (see below). Themes that were briefly men-
tioned during the baseline interviews could then be
addressed in subsequent case study interviews. During
the phase of research covered in this paper, additional
interviews (n=3) were conducted at the case study site.
The eleven interviews were held in Dutch or English,
ranged from 60 to 90 minutes, and were recorded and
transcribed verbatim.
Qualitative study - case study
As part of the larger evaluation of the 22 disease man-
agement programmes, five case study sites were cho-
sen for in-depth research. Interviews with all of the 22
project managers as well as document analysis were
used to select five cases for ethnographic ‘thick
descriptions’. Criteria for selection were spread over
regions, patient groups and different kinds of targeted
interventions. One cardiovascular risk disease man-
agement programme (Radboud, see Table 1) was cho-
sen as a case study of the cardiovascular disease
management programmes. This programme focuses
on lifestyle improvement among high-risk patients,
such as weight-loss or smoking-cessation. Much
emphasis in the development of the programme has
been on creating arrangements that support patient-
centred care, such as an enhanced electronic patient
record. Two general practitioners lead the project
together with one nurse project manager, who is
responsible for communicating with the caregivers at
the sites.
Qualitative study – analysis
The interviews were inductively coded in two rounds. In
vivo coding (creating codes using words from the
empirical data, without paraphrasing) of all comments
was used in the first round to determine a saturation
point (no new information) and generate an inductive
code list (paraphrasing and categorising). This list
was then used to code all the interviews and generate
overarching themes.
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Results of quantitative analysis
Analyses of variance showed that age, gender, marital
status, educational levels, disease-management level
(from the patient's perspective) and health-related
quality of life varied significantly among disease man-
agement programmes (all p<0.001; Table 2). Maars-
senbroek (low and high-risk patients) had the
youngest population (mean age=59.80, s.d. 9.65)
and Radboud (low and high-risk patients) the oldest
(mean age=67.82, s.d. 9.90). The majority of Stichting
Eerstelijns Samenwerking Achterveld respondents
(diagnosed and high-risk patients) were married
(89%); other programmes had substantially lower per-
centages, especially Onze Lieve Vrouwe Gasthuis
(diagnosed patients) (56%) and Regionale Organisatie
Huisartsen Amsterdam (diagnosed patients) (61%).
More patients at Huizen (high-risk patients) and
Maarssenbroek had a high education status (71%),
as opposed to 60% in the other programmes.
Patient-perceived disease-management level was
highest in Rijnstate (high-risk patients) and lowest in
Regionale Organisatie Huisartsen Amsterdam.
Health-related quality of life was highest at Stichting
Eerstelijns Samenwerking Achterveld and lowest at
Onze Lieve Vrouwe Gasthuis, Regionale Organisatie
Huisartsen Amsterdam and Radboud.
Table 3 presents the associations between disease
management programmes, patient characteristics,
and disease-management level and health-related
quality of life as estimated through multiple regression
analysis. Results show that health-related quality of
life is significantly lower at Onze Lieve Vrouwe
Gasthuis, Regionale Organisatie Huisartsen Amster-
dam, Radboud and Huizen. Age (β=−0.11; p≤0.001)
and being female (β=−0.11; p≤0.001) are negatively
associated with health-related quality of life. Being mar-
ried (β=0.12; p<0.001) and having a higher level of edu-
cation (β=0.11; p<0.001) are related to a better quality
of life, but patient-assessed disease-management level
is not related to quality of life.
Table 2. Descriptive statistics of patient characteristics, experiences with chronic care and health-related quality of life
Region OLVG SESA ROHA SGE Maarssen-broek Rijnstate Radboud Huizen Total
Age mean 67.15 63.93 65.03 63.33 59.80 63.40 67.82 65.75 64.10
SD 10.44 8.56 9.00 10.44 9.63 10.35 9.90 10.16
Female 43% 41% 40% 57% 56% 53% 42% 41% 48%
Married 56% 89% 61% 74% 77% 79% 76% 75% 74%
Higher educated 60% 57% 60% 59% 71% 55% 57% 71% 62%
PACIC mean 2.68 2.82 2.42 2.63 2.81 2.85 2.69 2.49 2.69
SD 0.83 0.94 0.79 0.78 0.87 0.81 0.88 0.84 0.85
EQ5D mean 0.67 0.89 0.68 0.79 0.81 0.82 0.68 0.76 0.78
SD 0.16 0.14 0.27 0.20 0.22 0.21 0.26 0.20 0.20
Note: Analysis of variance: Age (Fgroup =14.9; p<0.001); Female (Chi-square 29.1; p<0.001); Married (Chi-square 57.3;
p<0.001); Higher educated (Chi-square 25.5; p<0.001); Pacic (Fgroup=6.1; p<0.001); EQ5D (Fgroup=6.5; p<0.001).
Table 3. Multiple regression analysis of disease management
programmes and patient characteristics on health-related quality of
life
Beta
DMPs
OLVG −0.07*
SESA 0.05
ROHA −0.10**
SGE 0.01
Rijnstate 0.01
Radboud −0.11***
Huizen −0.09**
Demographics
Age −0.11***
Female −0.11***
Married 0.13***
Higher educated 0.11***
PACIC 0.00
Adjusted R2 for equation 0.14
F Change 12.33
Note: Reference care group is Maarssenbroek. DMPs=
Disease Management Programmes.
*p≤.05; **p ≤0.01; *** p ≤0.001.
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Direct costs of disease management
programme development
The development costs of the eight disease manage-
ment programmes are presented in Table 4. Total
development costs varied considerably (from €26,807
to €274,783). Two important factors contributing to
this variation in costs were the duration of the develop-
ment phase (longer duration was associated with
higher costs) and the number of different professionals
involved in programme development. In all disease
management programmes, labour costs accounted for
more than two-thirds of total costs. Information and
communications technology did not contribute substan-
tially to the total development costs.
Direct costs of health care utilisation
Table 5 presents the descriptive statistics of the 3-
month costs of health care utilisation per disease man-
agement programme. The mean total health care costs
were €350 per patient. There was a wide variation
among programmes, with total health care costs ran-
ging from €252 to €628 per patient. The mean health
care professional costs were €258 when averaged
over all patients and €305 when averaged over the
patients who contacted at least one health care profes-
sional during the last 3 months (85% of all patients).
Mean hospitalisation costs were €855 averaged over
all patients and €7399 per patient who had at least
one hospital admission (1% of all patients). The mean
pharmaceutical costs were €31 per patient and €37
per patient who reported medication use (95% of all
patients).
Results of qualitative analysis
Developing and implementing a patient-centred dis-
ease management care pathway with multiple provi-
ders requires a transformation for both the providers
and the patients. Although research has shown that
new systems of care for chronic illness can improve
delivery of care and patient outcomes [35], their distri-
bution of care responsibilities, and especially the time
commitment needed to organise doctors and coordi-
nate with other providers, are prevalent concerns.
Project leader interviews revealed initial concerns
about organisational challenges, identifying the target
population activating patients and proper Information
and Communication Technology support for these
processes.
Organisational challenges
In the development and implementation of the disease
management programme, the project leaders and man-
ager focused on the organisational challenges of work-
ing with large teams and developing a solid basis for
programme implementation.
It takes considerable time to clearly get what everyone
wants and what everyone already does. I do not know
your experience with doctors, but here it is true that every
doctor has a different approach and style. There is very little
consistency. (Project leader at A)
We could have just started and waited to see what we would
encounter. But we wanted to start by laying a good founda-
tion and then trying to build from there. (Interview with H,
programme manager)
Although the respondents emphasise laying a ‘good
foundation’ and creating consistency in practice, they
still encounter challenges in coordinating care between
multiple providers. These challenges are magnified as
the care pathway extends beyond the General Practi-
tioner office building.
Practices are very large organisations. So first, you must
convince people of the importance of doing the research.
That takes a lot of effort.... Plus, you should also involve
other members of the care teams, the physical therapist,
the nutritionist. Later, I found a missed opportunity, in that
we have no contact with pharmacists. That we just forgot.
So, this is probably something we'll have to fix. (Interview
with M, X, H)
Communication between the project leadership team
and other care providers can be difficult because prac-
tices have their own processes, protocols, and priorities
in care giving. While the project leadership team placed
emphasis on creating a good foundation early in the
project timeline, the effort of organising the disease
management programme remains a work in progress.
Activating patients
Through patient-centred care, patients are made
responsible for choosing how they want to change
(and presumably improve) their lifestyle. The clinician,
formerly a directive force in health care, takes on a
more collaborative role and decides together with the
patient how to manage a given health issue.
We are not used to patient-centred working. The doctor says
to the patient, you must stop smoking and eat more healthy
food. Then the patient goes home. And yeah, the doctor can
tell this, but we let the patients choose for themselves and
we hope that we have convinced them. But the patients
can choose their own risk factor to change. (Interview
with X)
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Such developments demonstrate a more general shift
in health care towards a more 'active’ role for patients,
but this approach implies that patients not only have
both the knowledge of cardiovascular risk factors and
a desire to change behaviours related to these risk fac-
tors, but also the ability to make the suggested
changes to improve their health and health care.
Electronic health records
To organise multidisciplinary, patient-centred care path-
ways, the organisations are implementing electronic
health records that connect the various clinicians and
allow them to access patient information from any inter-
net-friendly location. But implementing Information and
Table 5. Descriptive statistics of health care utilisation costs in three months period (in euros)
OLVG
n=124
Heelkom
n=111
ROHA
n=209
SGE
n=134
Maarssenbroek
n=307
Rijnstate
n=262
Radboud
n=232
Huizen
n=157
Total
N=1536
Costs of:
Healthcare professionals
N 124 111 209 134 307 262 232 157 1536
Mean 328.70 167.33 375.02 233.44 236.24 230.07 257.45 218.02 257.65
SD 447.34 234.41 525.45 334.09 372.23 286.09 345.74 253.18 369.33
with
contact
87% 85% 86% 84% 81% 91% 84% 78% 85%
Mean 377.40 197.60 435.44 276.82 292.45 252.21 307.88 278.28 304.66
SD 459.88 242.79 542.56 347.03 393.89 290.09 357.02 255.06 383.37
Hospitalisation
N 112 111 186 127 284 247 196 145 1408
Mean 65.52 61.86 240.97 46.63 0.00 69.40 13.90 78.43 68.31
SD 693.38 651.69 1938.96 525.49 0.00 696.09 194.64 666.05 854.93
with
contact
1% 1% 2% 1% 0% 1% 1% 1% 1%
Mean 7338.00 6866.00 11,205.25 5922.00 . 5714.33 2725.00 5686.00 7399.00
SD . . 8248.04 . . 3348.65 . 333.75 5190.36
Medication
N 116 111 196 131 302 253 224 154 1487
Mean 35.12 23.04 40.95 18.49 25.90 28.59 36.53 33.78 30.61
SD 33.53 22.30 34.55 19.20 32.77 30.47 34.94 27.19 31.49
Users 86% 77% 91% 74% 80% 81% 85% 90% 83%
Mean 40.73 29.74 45.09 24.97 32.46 35.12 43.07 37.69 36.83
SD 32.79 21.02 33.58 18.32 33.66 30.19 34.02 26.01 31.05
Total health care utilisation
N 124 111 209 134 307 262 232 157 1536
Mean 420.73 252.23 627.88 295.71 261.72 323.11 304.47 323.58 349.91
SD 811.61 778.14 2007.98 683.30 380.40 789.74 416.80 722.92 954.50
Users 94% 94% 93% 95% 95% 96% 93% 96% 95%
Mean 445.90 269.21 672.95 312.00 276.12 335.93 328.55 336.44 370.15
SD 828.94 801.27 2071.83 698.36 385.62 802.63 423.77 734.28 977.91
Note: Analysis of variance for health care utilisation. All: care givers (Fgroup =5.4; p<0.001); hospitalisation (Fgroup=1.5;
p>0.05); medication (Fgroup=9.9; p<0.001); total health care utilisation (Fgroup =3.4; p<0.001); with contact/users: care givers
(Fgroup =5.6; p<0.001); hospitalisation (Fgroup=0.4; p>0.05); medication (Fgroup=6.8; p<0.001); total health care utilisation
(Fgroup =3.5; p<0.001);
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Communication Technology systems brings a new set
of challenges:
We have had a lot of barriers. The first barrier is with the ICT
system. We didn't receive it already finished… It has been a
long road to get to where we are now. (Interview with X) It is
not easy – GPs are always very busy. And when the project
started, I had to change the daily practices, the rules. They
must use another screen and work with patients in a differ-
ent way than they are used to. So it's not easy to implement
this in our daily practices. (Interview with X)
As these quotes show, implementing computer-based
systems involves a number of organisational, cultural,
and technical changes that slow progression in the dis-
ease management programmes.
Discussion
In absence of adequate descriptions of on-going cardi-
ovascular disease management programmes, this
study described the varieties in patient characteristics,
quality of chronic care delivery, health care utilisation
costs, development costs, and patient outcomes
among newly developed cardiovascular disease man-
agement programmes in the Netherlands. Improve-
ments from disease management programmes in
terms of care and costs have been documented
[19,20], but results vary widely across health care set-
tings and target groups [23–25]. Given the challenging
tasks of developing complex, multi-component inter-
ventions and transitioning from acute to chronic care,
we therefore investigated challenges that occurred dur-
ing the implementation phase and assessed financial
and organisational development costs.
The impacts of cardiovascular disease management
programmes are expected to depend on patient char-
acteristics [8,36]. Results of this study showed that
patient characteristics, disease-management level,
and health-related quality of life all varied widely among
the cardiovascular disease management programmes.
In this cross sectional study, no relationship was found
between patients’ perceived disease management
level and health-related quality of life. This, however,
is not surprising because we studied the early stages
of cardiovascular disease management programmes.
We expect to find a significant relationship in the long
run. Programmes coping with older, less educated
patients with poor health-related quality of life poten-
tially have a harder time attaining improved patient out-
comes, because it is more difficult for such patients to
change lifestyle, adhere to treatment recommendations
and ask for additional support. However, if the care
being delivered is tailored to the specific needs of these
vulnerable groups, it also offers the chance for greater
improvement.
Our cost analysis and the description of actions per-
formed within the context of cardiovascular disease
management programmes revealed significant differ-
ences, with total development costs varying consider-
ably between the eight programmes. The duration of
the development period and the number of different
disciplines involved in this phase might explain this var-
iation. For example Stichting Gezondheidscentra Eind-
hoven had the highest development costs due to the
relatively long development period (18 months) and
the relatively high involvement (in fte's) of many of dif-
ferent disciplines (11) in the preparation of this pro-
gram. This relatively intensive and lengthy preparation
process may reflect the variety and complexity of dis-
ease management interventions provided by Stichting
Gezondheidscentra Eindhoven. In general terms,
spending much time in the developing phase leads to
higher costs due to high labour costs. Although labour
costs appear to vary substantially among programmes,
they account for more than 80% of total costs in all pro-
grammes. Using only baseline data, it is currently not
possible to provide further insight into the relationship
between the complexity of the programme and the
costs. This data is, however, currently being gathered
and can be reported on in a later phase.
Our qualitative analysis suggests the need to consider
more carefully the potential consequences of develop-
ing and implementing complex, multi-component inter-
ventions and patient-centred integrated care pathways
for primary care. While the primary care setting is
thought to be an ideal location for the coordination of
care [37], this can be time consuming and significantly
costly for practices where coordinated care is a new
endeavour, and especially when the goal is sustainable
change. While project leaders take steps to be efficient
when developing and implementing programmes, as it
can be seen in the qualitative data on creating a good
foundation, organising and training health care provi-
ders is also time-consuming. Although this is largely
unavoidable due to the complexities involved in chan-
ging practice structures, working with multiple care pro-
viders, transforming the patient/provider relationship,
and developing computer-based health systems, the
resulting delays are important findings since the length
of development is the main cost driver.
Given recent attention for high costs of implementing
Information and Communication Technology systems
in health care [38], we expected information and com-
munications technology costs to be an important cost
driver; however, cost analysis results indicated that,
during the development phase, they were by far out-
weighed by the labour costs. Importantly, though, our
qualitative study revealed that they could be indirectly
significant by delaying the implementation process,
thereby increasing the length of the development
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period, which is the main cost driver. Even when imple-
mented, such systems remain a work in progress and
may not provide the improvement in care desired
[39,40]. Because the task of system development is
usually contracted out to computer programmers and
software developers, this reduces the autonomy that
project leaders have over the timeline, the computer-
based programme, and, consequently, the costs. The
important lesson for those wanting to implement cardi-
ovascular disease management programmes is to be
prepared for and aware of these challenges.
Some study parameters are notable. Although we
evaluated a diverse set of eight cardiovascular disease
management programmes, general measures given to
each site did yield a solid evidence base. Moreover, in
combination with the qualitative descriptions, the varia-
tion between sites contributed to deeper understanding
of the relationship between the complexity of a project,
implementation challenges and related costs. The
response rate of 54% among patients may have affected
our study findings. For example if non-responders
mainly consisted of patients with more severe conditions
health-related quality of life may be overestimated.
Furthermore, response rates among practices with lower
socioeconomic status patients were lower, which indi-
cates selection bias and possible confounding.
We do not know to what extent other policy issues influ-
enced the development and implementation of the dis-
ease management programmes. For example the
Dutch Ministry of Health has recently introduced an inte-
grated payment system, the Chain-Diagnosis Treat-
ment Combination (chain-DTC), which combines the
costs of multiple professionals working primarily in gen-
eral or primary care and, to a limited extent, in specia-
lised or hospital-based outpatient care. The chain-DTC
stimulates cooperation among different providers of
curative interventions in primary-care settings (e.g.
General Practitioners, practice assistants, physiothera-
pists, dieticians). While, expectations of such an inte-
grated payment system were high, practice shows that
most cardiovascular disease management pro-
grammes are not financed via a chain-DTC yet. The
cross-sectional study design meant we could describe
only the current situation and relationships. We could
not answer the question why some cardiovascular dis-
ease management programmes seem to work better
than others. Future research will enable us to identify
predictors of health-related quality of life and give insight
into which types of programme interventions enhance
health-related quality of life in cardiovascular disease
patient groups. Future research is also necessary to
investigate whether a higher disease-management
level indeed positively affects health-related quality of
life. Because our study was conducted in the specific
healthcare setting of theNetherlands, comparing results
to other countries using the same mixed-methods
approach and in-depth description of interventions
would be useful to further our understanding of the influ-
ence of different financial structures and cultural set-
tings on creating sustainable integrated care pathways.
Conclusions
While improvements from disease management pro-
grammes in quality of care and cost-effectiveness
have been documented in the Netherlands [41–44],
the results vary widely across health care settings, dis-
eases, and target groups [23–25]. The current study
described eight cardiovascular disease management
programmes to give insight into the forms of disease
management and the feasibility of a disease manage-
ment approach. The results showed that disease man-
agement level, costs, health care utilisation, patient
characteristics, and health-related quality of life of
patients all varied widely among the cardiovascular dis-
ease management programmes. These variations are
expected to influence future programme outcomes,
cost-effectiveness and sustainability.
Implementing cardiovascular disease management pro-
grammes is time-consuming and challenging because
they demand complex, multifaceted changes in routine
care. Furthermore, as these care pathways become
more complex, they also become more expensive. In
the case of cardiovascular disease management pro-
grams, costs are to a large extent attributable to delays
in implementation.Therefore, better preparedness,
incremental implementation plans, and training might
reduce the implementation period and, thereby, costs.
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Appendix: overview of the eight cardiovascular disease
management programmes
Onze Lieve Vrouwe Gasthuis (OLVG)
The programme targets cardiovascular disease patients
diagnosed with: myocardial infarction; Angina Pectoris;
Stroke; Transient Ischaemic Attack; peripheral arterial
disease; aortic aneurysm. The core disease management
team consists of 6 professionals: the project leader (internist/
vascular specialist), the project coordinator (nurse
practitioner), two General Practitioners experienced in
cardiovascular diseases, a internist/vascular specialist and a
student/researcher. The overall disease management team
consists of thirty-seven professionals (17 General
Practitioners, 4 internists/vascular specialists, 3 cardiologists,
1 psychiatrist, 1 neurologist, 1 vascular surgeon, 1 nurse
practitioner, 8 practice nurses and the manager/project
leader) and the cardiovascular disease management
programme is implemented in five general practices. This
cardiovascular disease management programme focuses on
secondary prevention (body weight/blood pressure/
cholesterol/smoking/adherence to therapy). Neurologists,
vascular surgeons and cardiologists refer patients from the
secondary to primary cardiovascular disease management
programme, in which they aim to provide care according to
the same clinical guidelines used in the hospital.
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Patient-directed interventions:
. Use of Electronic Patient Record system that facilitates
online communication between patient and provider to
enhance self-management.
Professional-directed intervention:
. Implementation of care standard for cardiovascular risk
management
. Uniform treatment protocols in primary and hospital care
. Increase knowledge and independence of primary prac-
tice nurses and General Practitioners
. Benchmarking and auditing of patient satisfaction
Organisational intervention:
. Delegation of care from in-hospital (internist/vascular spe-
cialist and specialised nurse practitioner) to General Prac-
titioner and primary care practice nurse
. Redistribution of hospital to primary care
. Regular follow-up
. Intensification of cooperation with physiotherapists in
using existing exercise programmes
. Regional transmural Electronic Patient Record system
with a patient portal containing information on projects
and referral options
Stichting Eerstelijns Samenwerking
Achterveld (SESA)
The programme targets patients diagnosed with
cardiovascular disease or high-risk patients. They are
located in a rural area with a population that consists of
relatively more people younger than 21 years, people above
65 years old, and mainly native Dutch people. They
especially focus on promoting a culture change in their
patients. In general their patients are not very assertive or
actively involved in managing their chronic condition. The
disease management team consists of nine professionals (3
General Practitioners, a dietician, a physiotherapist, an
administrator, project leader, physician-assistant and a
practice nurse) and the cardiovascular disease
management programme is implemented in one general
practice. They aim to work according to the cardiovascular
care standard.
Patient-directed interventions:
. Training of patient groups in active participation and self-
management (healthy diet, exercise, stress management)
Professional-directed intervention:
. Educational meetings on the disease management
programme
. Education and training in patient stimulation and support
to enhance their active involvement
. Setting quality parameters for auditing and feedback
Organisational intervention:
. Delegation of care from General Practitioner to practice
nurse, from heart specialist to General Practitioner
. Regular follow-up
. Integrated information system
. Implementation of regional transmural Electronic Patient
Record system in 3 years
Regionale Organisatie Huisartsen
Amsterdam (ROHA)
The programme targets patients with a history of a
cardiovascular event. The core team consists of seven
professionals (4 General Practitioners, project advisor,
cardiologist and a physician-assistant cardiovascular
diseases) and the cardiovascular disease management
programme is implemented in eight general practices. Two
General Practitioner practices located in the same region
proving care as usual serve as a control practice. Since
providing cardiovascular care is relatively new in primary
care a project team is set up with professionals working in
primary and secondary care. Regular meetings of this
project team are expected to create discussion, learning
experiences and knowledge.
Patient-directed interventions:
. Informational meetings (also in Turkish and Moroccan)
. Community-based lifestyle interventions
. Individual care plans
. Support of self-management with internet, email, text
messages, or incentives
. Lifestyle and exercise programmes
Professional-directed intervention:
. Basing General Practitioner primary care protocols on the
care standard cardiovascular risk management and the
Dutch College of General Practitioners (NHG) guidelines
. Education and training for lifestyle programmes
. Training cycle for General Practitioners
. Education of practice nurses in cardiovascular dis-
ease care
. Use of the Information and Communication Technology***
system for benchmarking
Organisational intervention:
. Use of the patient platform to implement self-management
programmes
. Communication with local immigrant organisations to
identify and mitigate potential barriers to immigrants’
involvement in disease management programmes
. Redistribution of hospital to primary care
. Delegation of care from specialist to General Practitioner
or practice nurse
. Regular follow-up
. Transmural care chain
. Cooperative agreements between primary and hospi-
tal care
. Special policies for immigrants
. Investigation of (im)possibilities for chain-integrated infor-
mation system with a patient portal
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Stichting Gezondheidscentra
Eindhoven (SGE)
The programme targets high risk cardiovascular disease
patients. The disease management team consists of one
hundred professionals
(46 General Practitioners, 27 physiotherapists, 17 practice
nurses, 10 dieticians) and the cardiovascular disease
management programme is implemented in ten general
practices. Care for cardiovascular disease patients is
already implemented within the General Practitioner
practices, but needs structure and coordination.
Patient-directed interventions:
. Patient education
. Personal coaching
. Motivational interviewing
. Facilitation of self-monitoring and self-management
. Customised programmes to quit smoking, exercise, main-
tain healthy diet and develop coping skills
Professional-directed intervention:
. Disease management programme education
. Training in motivational training
. Use of validated performance and process indicators as
quality parameters for auditing and feedback
. Individual monitoring of patients and evaluating quality of
care at group level
. Provision of feedback and suggestions for improvement
by the care registration team
Organisational intervention:
. General Practitioner as the central care provider in close
collaboration with the practice nurse
. Emphasis of care providers’ coaching role
. Exercise programmes provided by a consultant at regular
sports facilities
. Regular follow-up
. Cooperation with diagnostic centres and hospital care
specialists
. Cooperative agreements between primary and hospital care
. Early detection of high-risk patients
. Uniform systematic registration by all professionals
. Support of ICT-registration system for monitoring and
feedback
Gezondheidscentrum Maarssenbroek
The programme targets patients at risk for cardiovascular
disease. Low risk patients are seen annually and high risk
patients will receive lifestyle interventions. Patients with a
history of cardiovascular diseases stay within secondary
care if necessary. The disease management team consists
of ten professionals (2 General Practitioners, internist, project
leader, a nurse practitioner, physiotherapist and four practice
nurses) and the cardiovascular disease management
programme is implemented in one general practice. They
had already implemented some elements of cardiovascular
care but with the disease management programme they aim
to expand cardiovascular care in a primary setting.
Patient-directed interventions:
. Lifestyle advisors and plans (exercise, diet, quit smoking)
. Exercise programmes
. Quit smoking consultation hours
. Development of individual patient care plans based on
their risk profiles
. Motivational interviewing
Professional-directed intervention:
. Cardiovascular programme based on the care standard
for cardiovascular risk management
. Training in motivational interviewing
. Setting quality parameters for auditing and feedback
. Benchmarking
. Regular intervention and goals evaluation by central care
director
Organisational intervention:
. Mapping of patients’ wishes and active involvement of
patients or patient groups in the cardiovascular disease
programme
. Annual patient satisfaction inquiry
. Central care director (nurse practitioner) responsible for
content of the care plan, delegation of lifestyle interven-
tions to the lifestyle advisor, regular meetings with the
pharmacist on patients’ medication use, and proactive
contact with other involved professionals
. Collaboration of lifestyle advisor and patient on coaching
and lifestyle plans
. Cardiovascular disease practice nurse consultation hours
4 times a week. Patient inflow through General Practi-
tioner and active involvement with at-risk patients
. Shared decision making and actively reminding patients
of their decisions and treatment plans
. Regular follow-up
. Expansion of chain care to hospital care
. Transmural protocol
. Chain-integrated information system with a patient portal
Ziekenhuis Rijnstate
The programme targets high-risk cardiovascular disease
patients. The core of the disease management team consists
of six of professionals (General Practitioner, internist,
cardiovascular nurse, project leader and 2 practice nurses)
and the cardiovascular disease management programme is
implemented in ten general practices. The innovative
element of this cardiovascular disease management
programme is its transmural nature. They aim to transfer
knowledge and expertise in cardiovascular care from
secondary to primary care.
Patient-directed interventions:
. Joint medical consultations for primary care and hospital
care patients (n=10), a spouse/family member, and a
physician
Professional-directed intervention:
. Improved implementation of guidelines for cardiovascular
care in primary and hospital settings
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. Implementation of care standard for cardiovascular risk
management to improve implementation of the Dutch Col-
lege of General Practitioners (NHG) guidelines in primary
and hospital care settings
. Education for General Practitioners
. Cooperative learning among nurses at the outpatient clinic
Organisational intervention:
. Knowledge exchange
. One-stop outpatient clinic
. Joint consultation hours
. Regular follow-up in primary care
. Cooperation between primary and hospital care
. Uniform treatment plan in primary and hospital care
. Early recognition of high-risk patients at outpatient clinics
and general practices
. Transmural Electronic Patient Record system vascular
risk management with a patient portal
. Development of transmural chain Diagnosis Treatment
Combination
UniversitairMedischCentrumStRadboud
The programme targets patient with the following criteria:
1 At least a year under treatment of a General Practitioner
or specialist due to cardiovascular disease risk.
2 Primarily starting with secondary prevention.
They also focus on patients with low socioeconomic
backgrounds. The disease management team consists of
twenty-three professionals (11 General Practitioners, 3
physiotherapists, 2 dieticians, a internist, project leader and
5 practice nurses) and the cardiovascular disease
management programme is implemented in two general
practices and two general practices in the area providing
usual care serve as control group. They aim to establish
systematic transmural collaborative care in the disease
management programme for which they will implement a
structure that enhances cooperation between professionals
within the disease management programme.
Patient-directed interventions:
. Patient-driven choice programme: patient can choose a
central care provider, the risk factor(s) he/she wants to
tackle, the intervention(s), personal goals, and use of
web-based support
. Individual care plans with personal goals
. Motivational interviewing
. Self-management support with vulnerable groups
. Cognitive behavioural therapy
Professional-directed intervention:
. Implementation of care standard for cardiovascular risk
management
. Training in motivational interviewing
. Education of professionals
. Auditing and feedback sessions to improve quality of
patient satisfaction and outcomes
Organisational intervention:
. Internist and vascular nurse as central care providers
. Regular follow-up
. Contact with unmotivated patients every 3 months
. Development of transmural collaborative care structure
. Enhanced interaction and cooperation among profes-
sionals involved in the disease management programme
on referrals and treatment plans
. Contact with patients of low socioeconomic status and dif-
ferent cultural backgrounds
. Development of online patient files accessible to all pro-
fessionals and the patient
. Registration of risk profiles in the ICT system
Wijkgezondheidscentra Huizen
The programme targets patients with a higher risk for
cardiovascular diseases. The disease management team
consists of eight professionals (2 General Practitioners, practice
nurse, project leader, pharmacist, physiotherapist, dietician and
manager) and the cardiovascular disease management
programme is implemented in two general practices.
Patient-directed interventions:
. Education of patients to enhance self-management skills
. Individual care plans
. Motivational interviewing
. Exercise programmes
. Quit smoking counselling
. Healthy diet counselling
. Web-based support programmes to enhance self-man-
agement (access patient file, information, e-consultation)
Professional-directed intervention:
. Implementation of care standard for cardiovascular risk
management
. Education of professionals on informing patients and train-
ing in motivational interviewing
. Education of physician's assistants on cardiovascular risk
factors
. Auditing and feedback on performance indicators and
benchmarking
Organisational intervention:
. Consultation with several patient groups
. Patient satisfaction research
. Delegation of care from General Practitioner to practice
nurse
. Practice nurse as central care provider
. Identification of patient groups based on risk profiles
. Pharmacist monitoring of medication
. Physical therapist-run exercise programmes
. Healthy diet counselling from practice nurse in collabora-
tion with dietician
. Development of multidisciplinary treatment programme for
obesity
. Registration of risk profiles
. Structural knowledge exchange
. Regular follow-up
. Cardiovascular counselling hours
. Cooperation between primary and hospital care
. Development of a multidisciplinary programme for obesity
. Professional information exchange in the ICT system
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